As a film director, Asian American, father and general consumer of news and culture, I consider myself well-versed in many things, especially when it comes to issues impacting my community. Though I recently found myself embarrassingly uneducated, and frankly shocked by a health issue that disproportionately affects Asian Americans: hepatitis B.
We have an opportunity to eliminate hepatitis C by taking appropriate and timely steps. We as a society should be willing to pay for the current HCV therapies -- for all patients -- by providing additional resources and giving the attention to hepatitis C that it deserves now. If we can do this, hepatitis C may be a nonissue by 2035.
The reality is that hepatitis C is the only deadly disease for which curative treatment is widely withheld from patients. Imagine if an insurer mandated that a cancer patient reach metastatic levels before receiving chemotherapy, or that a diabetic lose a limb before being eligible for insulin treatment.